PL95005B1 - - Google Patents

Download PDF

Info

Publication number
PL95005B1
PL95005B1 PL1975181325A PL18132575A PL95005B1 PL 95005 B1 PL95005 B1 PL 95005B1 PL 1975181325 A PL1975181325 A PL 1975181325A PL 18132575 A PL18132575 A PL 18132575A PL 95005 B1 PL95005 B1 PL 95005B1
Authority
PL
Poland
Prior art keywords
sulfanilamide
dihydro
pyrimidinyl
melting
water
Prior art date
Application number
PL1975181325A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL95005B1 publication Critical patent/PL95005B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/18Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

*** -sulfanilamidu i 280 ml 10% wodnego roztworu wodorotlenku sodowego ogrzewa sie w ciagu 1 go¬ dziny na. lazni parowej, rozciencza 280 ml wody, chlodzi do temperatury pokojowej i wkrapla 76 ml kwasu octowego. Otrzymuje sie 21,4 g surowe- 45 go N1-(l-cykloheksylo-l,2-dwuwodoro-2-keto-4-pi- rymidynylo)-sulfanilamidu o temperaturze topnie¬ nia 100—120°C w postaci drobnego osadu.Surowy produkt oczyszcza sie w sposób naste¬ pujacy. M Do roztworu 20,0 g otrzymanego zwiazku w 120 ml goracego etanolu wprowadza sie 11,5 g dwucykloheksyloaminy. Goracy roztwór saczy sie szybko, po czym pozostawia do krystalizacji po¬ czatkowo w temperaturze pokojowej, a nastep- 55 nie w ciagu nocy w szafie chlodniczej. Otrzymuje sie 15,8 g soli dwucykloheksyloaminowej N!-(l- -cykloheksylo-l,2-dwuwodoro-2-keto-4-pirymidy- nylo)-sulfanilamidu o temperaturze topnienia 126— 128°C. 60 ,5 g otrzymanej soli dwucykloheksyloaminowej miesza sie z 300 ml wody, 75 ml 10% wodnego roztworu wodorotlenku sodowego i 250 ml eteru.Warstwe eterowa oddziela sie, a faze wodna po¬ nownie przemywa 250 ml eteru. Roztwór wodny « 005 6 rozciencza sie nastepnie 1200 ml wody, ogrzewa do temperatury 90°C, szybko zakwasza 15 ml kwa¬ su octowego i pozostawia w ciagu 3 dni. Otrzy¬ muje sie 8,50 g N^d-cykloheksylo-ll^-dwuwodoro- -2-keto-4-pirymidynyllo)-sulfanilamidu o tempera¬ turze topnienia 153—156°C w postaci osadu, któ¬ ry rozpuszcza sie w 60 ml goracego metanolu.Roztwór saczy sie, zateza do objetosci 25 ml i po¬ zostawia przez .noc do krystalizacji. Otrzymuje sie 7,10 g N1- -4-pirymidynylo)-sulfanilamidu, o temperaturze topnienia 155—(15»70C. ' Przyklad V. Mieszanine 169 mg N4-acetylo- N1-(l-cykloheksylo-l,2-dwuwodoro-5-metylo-2-ke- to-4-pirymidynylo)-sulfanilamidu i 1,7 ml 10% wodnego roztworu wodorotlenku sodowego ogrze¬ wa sie w ciagu 30 minut na lazni parowej, roz¬ ciencza taka sama iloscia wody i ponownie ogrze¬ wa w ciagu 30 minut. Mieszanine chlodzi sie, za-., kwasza wkraplajac kwas octowy, rozciencza 1 ml wody i pozostawia na okres 30 minut. 94 mg otrzy¬ manego surowego produktu (laczna wydajnosc 123 mg) rozpuszcza sie w 2 ml cieplego metanolu, po czym mieszanine zateza sie w strumieniu azo¬ tu do 1/4 objetosci. Otrzymuje sie 48,9 mg NM1- -cykloheksylo-l,2-dwuwodoroJ5-metylo^2-keto-4- -pirymidynylo)-sulfanilamidu o temperaturze to¬ pnienia 203—206°C.Przyklad VI. 1,010 g N^acetylo-NMl-etylo- -l,2-dwuwodoro-5-metylo-4-pirymidynylo)-sulfa- nilamidu ogrzewa sie w 10 ml 10% wodnego roz¬ tworu wodorotlenku sodowego na lazni parowej w ciagu 1 godziny. Mieszanine rozciencza sie 20 ml wody, chlodzi i zakwasza kwasem octowym.Osad przemywa sie woda, uzyskujac 0,72 g produktu o temperaturze topnienia 174—176°C. Po przekry¬ stalizowaniu 0,50 g tego produktu z 30 ml eta¬ nolu otrzymuje sie 0,35 g NMl-etylo-l^-dwuwo- doro-5-metylo-2-keto-4-pirymidynylo)-sulfanilami- du o temperaturze topnienia 176—178°C.Przyklad VII. 500 mg ^-acetylo-N^Cl-cyklo- p1ropylo-l,2-dwuwodoro-5-metyIo-2-keto^4-tpiirylmi- dynylo)-sulfanilamidu w 5 ml 10% wodnego roz¬ tworu wodorotlenku sodowego ogrzewa sie w cia¬ gu 1 godziny na lazni parowej. Nastepnie miesza¬ nine rozciencza sie 10 ml wody, chlodzi i za¬ kwasza 1 ml kwasu octowego. Osad poczatkowo oleisty zestala sie szybko. Osad ten odsacza sie, otrzymujac 332 mg produktu o temperaturze top¬ nienia 128—133°C. Po przekrystalizowaniu tego produktu z 7 ml etanolu otrzymuje sie 120 mg NMl-cyklopropylo-l^-dwuwodoro-S-metylo^-ke- to-4-plrymidynylo)-sulfanilamidu o temperaturze topnienia 134—,136^0. PL PL PL PL PL

Claims (1)

1.
PL1975181325A 1974-06-19 1975-06-18 PL95005B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US480784A US3923792A (en) 1974-06-19 1974-06-19 Sulfacytosine derivatives

Publications (1)

Publication Number Publication Date
PL95005B1 true PL95005B1 (pl) 1977-09-30

Family

ID=23909351

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1975181325A PL95005B1 (pl) 1974-06-19 1975-06-18

Country Status (20)

Country Link
US (1) US3923792A (pl)
JP (1) JPS5113781A (pl)
AU (1) AU8222075A (pl)
BE (1) BE830360A (pl)
DD (1) DD118090A5 (pl)
DE (1) DE2526795A1 (pl)
DK (1) DK274575A (pl)
ES (1) ES438661A1 (pl)
FI (1) FI751786A7 (pl)
FR (1) FR2275218A1 (pl)
GB (1) GB1471399A (pl)
HU (1) HU170013B (pl)
IE (1) IE41563B1 (pl)
IL (1) IL47500A0 (pl)
LU (1) LU72748A1 (pl)
NL (1) NL7507154A (pl)
NO (1) NO752174L (pl)
PL (1) PL95005B1 (pl)
SE (1) SE7506907L (pl)
ZA (1) ZA752558B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54106635A (en) * 1978-01-30 1979-08-21 Mo Tekusuchiruni I Apparatus for separating fiber and supplying said fiber into spinning chamber
US5246931A (en) * 1988-10-25 1993-09-21 Bristol-Myers Squibb Company Carbocyclic nucleoside analogs
IL92096A0 (en) 1988-10-25 1990-07-12 Abbott Lab Carboxylic nucleoside analogs
US5153352A (en) * 1988-10-25 1992-10-06 Bristol-Myers Squibb Company Process for preparation of intermediates of carbocyclic nucleoside analogs
US4988703A (en) * 1989-05-22 1991-01-29 Abbott Laboratories Carbocyclic nucleoside analogs with antiviral activity
ES2139588T3 (es) * 1991-03-05 2000-02-16 Ajinomoto Kk Derivado de ciclopropano.
US7973060B2 (en) * 2005-10-13 2011-07-05 Crystalgenomics, Inc. Fab I inhibitor and process for preparing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422098A (en) * 1962-12-14 1969-01-14 Ciba Geigy Corp Sulfanilamido-pyrimidines
US3457278A (en) * 1964-10-15 1969-07-22 Geigy Chem Corp Cyclopropyl-4-sulfanilamido-pyrimidines
US3375247A (en) * 1965-08-02 1968-03-26 Parke Davis & Co Heterocyclic compounds and methods for their production

Also Published As

Publication number Publication date
ZA752558B (en) 1976-03-31
SE7506907L (sv) 1975-12-22
ES438661A1 (es) 1977-03-01
NO752174L (pl) 1975-12-22
DD118090A5 (pl) 1976-02-12
HU170013B (pl) 1977-03-28
IE41563L (en) 1975-12-19
DE2526795A1 (de) 1976-01-08
FR2275218A1 (fr) 1976-01-16
JPS5113781A (pl) 1976-02-03
NL7507154A (nl) 1975-12-23
GB1471399A (en) 1977-04-27
DK274575A (da) 1975-12-20
FI751786A7 (pl) 1975-12-20
IL47500A0 (en) 1975-08-31
IE41563B1 (en) 1980-01-30
AU8222075A (en) 1976-12-23
BE830360A (fr) 1975-12-18
US3923792A (en) 1975-12-02
LU72748A1 (pl) 1976-11-11

Similar Documents

Publication Publication Date Title
PL95005B1 (pl)
DK155663B (da) Analogifremgangsmaade til fremstilling af n-oe6-(fluorsubstitueret phenoxy)-5-indanylaa-methansulfonamidderivater
CA1242725A (en) Antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes
GB2246778A (en) Propylamine derivatives
ES2025665T3 (es) Un procedimiento para preparar polimorfo b de cimetidina.
SU552896A3 (ru) Способ получени -арилсульфонил- "(3-азабициклоалкил)мочевин или их солей
US3839321A (en) 5-sulfamoyl-n-(2-substituted-ethyl) anthranilic acids
PL117941B1 (en) Process for preparing derivatives of thieno-/2,3-c/and-/3,2-c/pyridinespiridina
CN110240582B (zh) 一种具有抑制肿瘤细胞的黄酮衍生物及其制备方法与应用
US4161533A (en) 5-Sulfamoyl-orthanilic acids and process for their preparation
US3105090A (en) Derivatives of alkyl benzoic acid and salts thereof with bases
US3933807A (en) Preparation of cyanophenols
US3467710A (en) Beta-(4- or 5-phenyl-1-naphthalene) ethylamines
US4393072A (en) Thienylbenzoic acid derivatives
CA1152996A (en) Substituted pyrrolidinyl-benzoic acid derivatives and a process for their manufacture
Chi et al. Thiazole Research: Synthesis of 2-Phthalimidomethyl-4-N-diethylamino-methylthiazole
US2483137A (en) Synthesis of vitamin b6
US2450777A (en) Sulfamyl-2-mercaptobenzothiazoles
PL117925B1 (en) Process for preparing novel derivatives of 5,6-dihydroimidazo/5,1-a/isoquinolineazo/5,1-a/izochinolina
US3166572A (en) Substituted [(alpha-nitroalkyl)benzylthio] alkylamines
US3336323A (en) Certain tetrahydro and dihydro-pyrrole derivatives of 2-ethylthiophene
US2463831A (en) Amino alkyl benzoates
KR800001510B1 (ko) 벤조구아나민 유도체의 제법
SU466228A1 (ru) Способ получени 2,4-дифенил-7,7диметилтетрагидропирано(4,3-в)пиперидина
Kakimoto et al. Antituberculous Compounds. XXII. 1 Monoalkylaminobenzothioamides